Loading…
Enroll-HD: An Integrated Clinical Research Platform and Worldwide Observational Study for Huntington's Disease
Established in July 2012, Enroll-HD is both an integrated clinical research platform and a worldwide observational study designed to meet the clinical research requirements necessary to develop therapeutics for Huntington's disease (HD). The platform offers participants a low-burden entry into...
Saved in:
Published in: | Frontiers in neurology 2021-08, Vol.12, p.667420-667420 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c465t-e3538498a2c33a7299392d8d5ce36aaf09b61c0c2a38a7605c371bfc33cc00043 |
---|---|
cites | cdi_FETCH-LOGICAL-c465t-e3538498a2c33a7299392d8d5ce36aaf09b61c0c2a38a7605c371bfc33cc00043 |
container_end_page | 667420 |
container_issue | |
container_start_page | 667420 |
container_title | Frontiers in neurology |
container_volume | 12 |
creator | Sathe, Swati Ware, Jen Levey, Jamie Neacy, Eileen Blumenstein, Robi Noble, Simon Mühlbäck, Alzbeta Rosser, Anne Landwehrmeyer, G Bernhard Sampaio, Cristina |
description | Established in July 2012, Enroll-HD is both an integrated clinical research platform and a worldwide observational study designed to meet the clinical research requirements necessary to develop therapeutics for Huntington's disease (HD). The platform offers participants a low-burden entry into HD research, providing a large, well-characterized, research-engaged cohort with associated clinical data and biosamples that facilitates recruitment into interventional trials and other research studies. Additional studies that use Enroll-HD data and/or biosamples are built into the platform to further research on biomarkers and outcome measures. Enroll-HD is now operating worldwide in 21 countries at 159 clinical sites across four continents-Europe, North America, Latin America, and Australasia-and has recruited almost 25,000 participants, generating a large, rich clinical database with associated biosamples to expedite HD research; any researcher at a verifiable research organization can access the clinical datasets and biosamples from Enroll-HD and nested studies. Important operational features of Enroll-HD include a strong emphasis on standardization, data quality, and protecting participant identity, a single worldwide study protocol, a flexible EDC system capable of integrating multiple studies, a comprehensive monitoring infrastructure, an online portal to train and certify site personnel, and standardized study documents including informed consent forms and contractual agreements. |
doi_str_mv | 10.3389/fneur.2021.667420 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_5d013e8a023148618b561b5017ef9db8</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_5d013e8a023148618b561b5017ef9db8</doaj_id><sourcerecordid>2569617888</sourcerecordid><originalsourceid>FETCH-LOGICAL-c465t-e3538498a2c33a7299392d8d5ce36aaf09b61c0c2a38a7605c371bfc33cc00043</originalsourceid><addsrcrecordid>eNpVkV1PHCEUhidNm2qsP6A3DXftzax8DQO9aGJW293ExKYf6SVh4MyKYcECY-O_76yrRrmBwHOec8jbNO8JXjAm1ckYYcoLiilZCNFzil81h0QI3lKqutfPzgfNcSnXeF5MKSbY2-aAcS45VvywiecxpxDa1dlndBrROlbYZFPBoWXw0VsT0A8oYLK9Qt-DqWPKW2SiQ39SDu6fd4AuhwL51lSf4kz_rJO7QzOGVlOsPm5qih8LOvOzpMC75s1oQoHjh_2o-f31_Ndy1V5cflsvTy9ay0VXW2Adk1xJQy1jpqfz3Io66ToLTBgzYjUIYrGlhknTC9xZ1pNhnGFr539ydtSs916XzLW-yX5r8p1Oxuv7i5Q32uTqbQDdOUwYSIMpI1wKIodOkKHDpIdRuUHOri971800bMFZiDWb8EL68iX6K71Jt1pyIhjeCT49CHL6O0GpeuuLhRBMhDQVTTuhBOml3KFkj9qcSskwPrUhWO9i1_ex613seh_7XPPh-XxPFY8hs___K6oX</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2569617888</pqid></control><display><type>article</type><title>Enroll-HD: An Integrated Clinical Research Platform and Worldwide Observational Study for Huntington's Disease</title><source>PubMed Central</source><creator>Sathe, Swati ; Ware, Jen ; Levey, Jamie ; Neacy, Eileen ; Blumenstein, Robi ; Noble, Simon ; Mühlbäck, Alzbeta ; Rosser, Anne ; Landwehrmeyer, G Bernhard ; Sampaio, Cristina</creator><creatorcontrib>Sathe, Swati ; Ware, Jen ; Levey, Jamie ; Neacy, Eileen ; Blumenstein, Robi ; Noble, Simon ; Mühlbäck, Alzbeta ; Rosser, Anne ; Landwehrmeyer, G Bernhard ; Sampaio, Cristina</creatorcontrib><description>Established in July 2012, Enroll-HD is both an integrated clinical research platform and a worldwide observational study designed to meet the clinical research requirements necessary to develop therapeutics for Huntington's disease (HD). The platform offers participants a low-burden entry into HD research, providing a large, well-characterized, research-engaged cohort with associated clinical data and biosamples that facilitates recruitment into interventional trials and other research studies. Additional studies that use Enroll-HD data and/or biosamples are built into the platform to further research on biomarkers and outcome measures. Enroll-HD is now operating worldwide in 21 countries at 159 clinical sites across four continents-Europe, North America, Latin America, and Australasia-and has recruited almost 25,000 participants, generating a large, rich clinical database with associated biosamples to expedite HD research; any researcher at a verifiable research organization can access the clinical datasets and biosamples from Enroll-HD and nested studies. Important operational features of Enroll-HD include a strong emphasis on standardization, data quality, and protecting participant identity, a single worldwide study protocol, a flexible EDC system capable of integrating multiple studies, a comprehensive monitoring infrastructure, an online portal to train and certify site personnel, and standardized study documents including informed consent forms and contractual agreements.</description><identifier>ISSN: 1664-2295</identifier><identifier>EISSN: 1664-2295</identifier><identifier>DOI: 10.3389/fneur.2021.667420</identifier><identifier>PMID: 34484094</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>clinical research platform ; disease network ; Enroll-HD ; Huntington's disease ; longitudinal observational cohort study ; Neurology ; registry</subject><ispartof>Frontiers in neurology, 2021-08, Vol.12, p.667420-667420</ispartof><rights>Copyright © 2021 Sathe, Ware, Levey, Neacy, Blumenstein, Noble, Mühlbäck, Rosser, Landwehrmeyer and Sampaio.</rights><rights>Copyright © 2021 Sathe, Ware, Levey, Neacy, Blumenstein, Noble, Mühlbäck, Rosser, Landwehrmeyer and Sampaio. 2021 Sathe, Ware, Levey, Neacy, Blumenstein, Noble, Mühlbäck, Rosser, Landwehrmeyer and Sampaio</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c465t-e3538498a2c33a7299392d8d5ce36aaf09b61c0c2a38a7605c371bfc33cc00043</citedby><cites>FETCH-LOGICAL-c465t-e3538498a2c33a7299392d8d5ce36aaf09b61c0c2a38a7605c371bfc33cc00043</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416308/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416308/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,882,27905,27906,53772,53774</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34484094$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sathe, Swati</creatorcontrib><creatorcontrib>Ware, Jen</creatorcontrib><creatorcontrib>Levey, Jamie</creatorcontrib><creatorcontrib>Neacy, Eileen</creatorcontrib><creatorcontrib>Blumenstein, Robi</creatorcontrib><creatorcontrib>Noble, Simon</creatorcontrib><creatorcontrib>Mühlbäck, Alzbeta</creatorcontrib><creatorcontrib>Rosser, Anne</creatorcontrib><creatorcontrib>Landwehrmeyer, G Bernhard</creatorcontrib><creatorcontrib>Sampaio, Cristina</creatorcontrib><title>Enroll-HD: An Integrated Clinical Research Platform and Worldwide Observational Study for Huntington's Disease</title><title>Frontiers in neurology</title><addtitle>Front Neurol</addtitle><description>Established in July 2012, Enroll-HD is both an integrated clinical research platform and a worldwide observational study designed to meet the clinical research requirements necessary to develop therapeutics for Huntington's disease (HD). The platform offers participants a low-burden entry into HD research, providing a large, well-characterized, research-engaged cohort with associated clinical data and biosamples that facilitates recruitment into interventional trials and other research studies. Additional studies that use Enroll-HD data and/or biosamples are built into the platform to further research on biomarkers and outcome measures. Enroll-HD is now operating worldwide in 21 countries at 159 clinical sites across four continents-Europe, North America, Latin America, and Australasia-and has recruited almost 25,000 participants, generating a large, rich clinical database with associated biosamples to expedite HD research; any researcher at a verifiable research organization can access the clinical datasets and biosamples from Enroll-HD and nested studies. Important operational features of Enroll-HD include a strong emphasis on standardization, data quality, and protecting participant identity, a single worldwide study protocol, a flexible EDC system capable of integrating multiple studies, a comprehensive monitoring infrastructure, an online portal to train and certify site personnel, and standardized study documents including informed consent forms and contractual agreements.</description><subject>clinical research platform</subject><subject>disease network</subject><subject>Enroll-HD</subject><subject>Huntington's disease</subject><subject>longitudinal observational cohort study</subject><subject>Neurology</subject><subject>registry</subject><issn>1664-2295</issn><issn>1664-2295</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkV1PHCEUhidNm2qsP6A3DXftzax8DQO9aGJW293ExKYf6SVh4MyKYcECY-O_76yrRrmBwHOec8jbNO8JXjAm1ckYYcoLiilZCNFzil81h0QI3lKqutfPzgfNcSnXeF5MKSbY2-aAcS45VvywiecxpxDa1dlndBrROlbYZFPBoWXw0VsT0A8oYLK9Qt-DqWPKW2SiQ39SDu6fd4AuhwL51lSf4kz_rJO7QzOGVlOsPm5qih8LOvOzpMC75s1oQoHjh_2o-f31_Ndy1V5cflsvTy9ay0VXW2Adk1xJQy1jpqfz3Io66ToLTBgzYjUIYrGlhknTC9xZ1pNhnGFr539ydtSs916XzLW-yX5r8p1Oxuv7i5Q32uTqbQDdOUwYSIMpI1wKIodOkKHDpIdRuUHOri971800bMFZiDWb8EL68iX6K71Jt1pyIhjeCT49CHL6O0GpeuuLhRBMhDQVTTuhBOml3KFkj9qcSskwPrUhWO9i1_ex613seh_7XPPh-XxPFY8hs___K6oX</recordid><startdate>20210818</startdate><enddate>20210818</enddate><creator>Sathe, Swati</creator><creator>Ware, Jen</creator><creator>Levey, Jamie</creator><creator>Neacy, Eileen</creator><creator>Blumenstein, Robi</creator><creator>Noble, Simon</creator><creator>Mühlbäck, Alzbeta</creator><creator>Rosser, Anne</creator><creator>Landwehrmeyer, G Bernhard</creator><creator>Sampaio, Cristina</creator><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20210818</creationdate><title>Enroll-HD: An Integrated Clinical Research Platform and Worldwide Observational Study for Huntington's Disease</title><author>Sathe, Swati ; Ware, Jen ; Levey, Jamie ; Neacy, Eileen ; Blumenstein, Robi ; Noble, Simon ; Mühlbäck, Alzbeta ; Rosser, Anne ; Landwehrmeyer, G Bernhard ; Sampaio, Cristina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c465t-e3538498a2c33a7299392d8d5ce36aaf09b61c0c2a38a7605c371bfc33cc00043</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>clinical research platform</topic><topic>disease network</topic><topic>Enroll-HD</topic><topic>Huntington's disease</topic><topic>longitudinal observational cohort study</topic><topic>Neurology</topic><topic>registry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sathe, Swati</creatorcontrib><creatorcontrib>Ware, Jen</creatorcontrib><creatorcontrib>Levey, Jamie</creatorcontrib><creatorcontrib>Neacy, Eileen</creatorcontrib><creatorcontrib>Blumenstein, Robi</creatorcontrib><creatorcontrib>Noble, Simon</creatorcontrib><creatorcontrib>Mühlbäck, Alzbeta</creatorcontrib><creatorcontrib>Rosser, Anne</creatorcontrib><creatorcontrib>Landwehrmeyer, G Bernhard</creatorcontrib><creatorcontrib>Sampaio, Cristina</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Frontiers in neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sathe, Swati</au><au>Ware, Jen</au><au>Levey, Jamie</au><au>Neacy, Eileen</au><au>Blumenstein, Robi</au><au>Noble, Simon</au><au>Mühlbäck, Alzbeta</au><au>Rosser, Anne</au><au>Landwehrmeyer, G Bernhard</au><au>Sampaio, Cristina</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Enroll-HD: An Integrated Clinical Research Platform and Worldwide Observational Study for Huntington's Disease</atitle><jtitle>Frontiers in neurology</jtitle><addtitle>Front Neurol</addtitle><date>2021-08-18</date><risdate>2021</risdate><volume>12</volume><spage>667420</spage><epage>667420</epage><pages>667420-667420</pages><issn>1664-2295</issn><eissn>1664-2295</eissn><abstract>Established in July 2012, Enroll-HD is both an integrated clinical research platform and a worldwide observational study designed to meet the clinical research requirements necessary to develop therapeutics for Huntington's disease (HD). The platform offers participants a low-burden entry into HD research, providing a large, well-characterized, research-engaged cohort with associated clinical data and biosamples that facilitates recruitment into interventional trials and other research studies. Additional studies that use Enroll-HD data and/or biosamples are built into the platform to further research on biomarkers and outcome measures. Enroll-HD is now operating worldwide in 21 countries at 159 clinical sites across four continents-Europe, North America, Latin America, and Australasia-and has recruited almost 25,000 participants, generating a large, rich clinical database with associated biosamples to expedite HD research; any researcher at a verifiable research organization can access the clinical datasets and biosamples from Enroll-HD and nested studies. Important operational features of Enroll-HD include a strong emphasis on standardization, data quality, and protecting participant identity, a single worldwide study protocol, a flexible EDC system capable of integrating multiple studies, a comprehensive monitoring infrastructure, an online portal to train and certify site personnel, and standardized study documents including informed consent forms and contractual agreements.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>34484094</pmid><doi>10.3389/fneur.2021.667420</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1664-2295 |
ispartof | Frontiers in neurology, 2021-08, Vol.12, p.667420-667420 |
issn | 1664-2295 1664-2295 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_5d013e8a023148618b561b5017ef9db8 |
source | PubMed Central |
subjects | clinical research platform disease network Enroll-HD Huntington's disease longitudinal observational cohort study Neurology registry |
title | Enroll-HD: An Integrated Clinical Research Platform and Worldwide Observational Study for Huntington's Disease |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T23%3A28%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Enroll-HD:%20An%20Integrated%20Clinical%20Research%20Platform%20and%20Worldwide%20Observational%20Study%20for%20Huntington's%20Disease&rft.jtitle=Frontiers%20in%20neurology&rft.au=Sathe,%20Swati&rft.date=2021-08-18&rft.volume=12&rft.spage=667420&rft.epage=667420&rft.pages=667420-667420&rft.issn=1664-2295&rft.eissn=1664-2295&rft_id=info:doi/10.3389/fneur.2021.667420&rft_dat=%3Cproquest_doaj_%3E2569617888%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c465t-e3538498a2c33a7299392d8d5ce36aaf09b61c0c2a38a7605c371bfc33cc00043%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2569617888&rft_id=info:pmid/34484094&rfr_iscdi=true |